Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Relypsa Inc Announces Closing of Initial Public Offering


Wednesday, 20 Nov 2013 04:05pm EST 

Relypsa Inc announced the closing of its initial public offering of 7,877,500 shares of its common stock at an initial public offering price of $11.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 1,027,500 additional shares of common stock. Relypsa's common stock is listed on The NASDAQ Global Select Market under the trading symbol RLYP. All of the shares in the offering were offered by Relypsa. Relypsa estimates net proceeds from the offering to be approximately $77.9 million, after deducting underwriting discounts and commissions and estimated offering expenses. Morgan Stanley & Co. LLC, BofA Merrill Lynch and Cowen and Company are acting as joint book-running managers for the offering. Stifel and Wedbush PacGrow Life Sciences are acting as co-managers. 

Company Quote

30.76
0.41 +1.35%
26 Dec 2014